Biovail Launches Tiazac In Canada; Crystaal Corporation, Biovail's Newly Created Wholly-Owned Subsidiary, to Market.TORONTO, Canada--(BUSINESS WIRE)--April 15, 1997--Biovail Corporation International (NYSE NYSE See: New York Stock Exchange , TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency ) today announced it has received approval from the Health Protection Branch and has commenced marketing of Tiazac in Canada. Tiazac, Biovail's once-daily diltiazem product, is being marketed by a newly created wholly-owned subsidiary, Crystaal Corporation, and is available in dosage strengths of 120mg, 180mg, 240mg, 300mg and 360mg. Crystaal Corporation will market Tiazac directly to physicians, enabling Biovail to benefit from the extremely dynamic Canadian market. Crystaal will also be marketing Biovail's existing controlled release product portfolio, as well as select in-licensed products from third parties which were previously unavailable in Canada. The Company expects Crystaal Corporation, with its unique identity and portfolio, to become a significant force in the Canadian healthcare market. Biovail Corporation International is an international full-service pharmaceutical company, engaged in the formulation, clinical testing, registration and manufacture of drug products utilizing advanced drug delivery technologies. -0- "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward looking and are subject to risks and uncertainties, including the difficulty of predicting FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. CONTACT: Biovail Corporation International Eugene Melnyk Chairman of the Board Bob Podruzny Chief Financial Officer (416) 285-6000 or Investor Relations Investor relations The process by which the corporation communicates with its investors. : Donna Stein/Dan Durkin/Cindy Hintelmann Press: Stacy Berns Morgen-Walke Associates (212) 850-5600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion